Cochrane Clinical Answers - Access Denied - In children with cutaneous molluscum contagiosum, how does topical 5% imiquimod compare with placebo?

Question:In children with cutaneous molluscum contagiosum, how does topical 5% imiquimod compare with placebo?

EXCERPT of full Clinical Answer

This Cochrane Clinical Answer evaluates topical 5% imiquimod versus placebo in children with cutaneous molluscum contagiosum.

Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.

Are you a COCHRANE CLINICAL ANSWERS subscriber?

SUBSCRIBE NOW to read the full answer

A subscription to THE COCHRANE LIBRARY is required.